Verrica Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Verrica Pharmaceuticals

Access the complete profile.

Verrica Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	44 W Gay St Ste 400 West Chester, PA 19380

Note: Revenues for privately held companies are statistical evaluations.


Verrica Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Verrica Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Verrica Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Verrica Pharmaceuticals Annual Revenue and Growth Rate

Verrica Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Verrica Pharmaceuticals's revenues are gauged from an analysis of company filings.

Verrica Pharmaceuticals's Income Statement (based on Industry Averages)

Verrica Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Verrica Pharmaceuticals is developing and marketing. Verrica Pharmaceuticals doesn't have any recent trademark applications, indicating Verrica Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
REINVENTING SKIN SCIENCE Pharmaceutical products and preparations for the treatment of dermatological diseases	06/04/2021
YCANTH Pharmaceutical products and preparations for the treatment of dermatological diseases	07/30/2019
CANVARYN Pharmaceutical products and preparations, including for the treatment of dermatological diseases	05/17/2019

See all trademarks and details in the Full Report.

Market Share of Verrica Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Verrica Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Verrica Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FUJIREBIO DIAGNOSTICS	Malvern, PA	100
FLAMMA USA	Malvern, PA	6
SHIRE HOLDINGS US AG	Exton, PA	6
AMRING PHARMACEUTICALS	Berwyn, PA	4
VERRICA PHARMACEUTICALS	West Chester, PA	4
ITF PHARMA	Berwyn, PA	2

Future Competition: Verrica Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Verrica Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)